Skip to content
healthcare.dev

Lubiprostone

NDC 0480-3479, Lubiprostone, capsule, gelatin coated, from Teva Pharmaceuticals, Inc..

Product NDC
0480-3479
Status
Listed
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209920
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3479 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE8 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package
0480-3479-060048034790660 CAPSULE, GELATIN COATED in 1 BOTTLE (0480-3479-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e17b521e-2c25-4bef-82f9-7916fa79bca4
  • NADAC price for package 00480347906

    GET /v1/drugs/nadac/00480347906

Use it

Look up 0480-3479 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3479 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0480-3479. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.